0 XP   0   0   0

Relmada Therapeutics Inc
Buy or Sell?

I guess you are interested in Relmada Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Relmada Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Relmada Therapeutics Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Relmada Therapeutics Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Relmada Therapeutics Inc. The closing price on 2022-09-23 was $31.90 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Daily chart of Relmada Therapeutics Inc
Relmada Therapeutics Inc Daily Candlestick Chart

1.1. Profitability of Relmada Therapeutics Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin
  • Measures how much profit a company generates for each dollar of revenue.
  • Above 10% is considered healthy depending on the industry.
  • A net profit margin of 25% means that $0,25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Relmada Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-218.9%+218.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--242.4%+242.4%
TTM--275.9%+275.9%
YOY--335.9%+335.9%
5Y--469.8%+469.8%
10Y-218.9%-549.9%+331.0%
1.1.2. Return on Assets
  • Shows how profitable a company is in relation to its total assets.
  • Above 5% is considered healthy depending on the industry.
  • 5% return on assets means the company generated $0,05 for each $1 in assets.

Let's take a look of the Return on Assets trends of Relmada Therapeutics Inc:

  • The MRQ is -18.5%. Very bad. -2
  • The TTM is -24.6%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-18.5%TTM-24.6%+6.1%
TTM-24.6%YOY-19.1%-5.5%
TTM-24.6%5Y-51.6%+27.0%
5Y-51.6%10Y-64.4%+12.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.5%-9.8%-8.7%
TTM-24.6%-8.8%-15.8%
YOY-19.1%-9.2%-9.9%
5Y-51.6%-11.6%-40.0%
10Y-64.4%-12.7%-51.7%
1.1.3. Return On Equity
  • Measures the profit in relation to shareholders equity (total assets - total liabilities).
  • Above 15%-20% is considered healthy depending on the industry
  • 10% return on equity means the company generated $0,1 for each $1 the owners (shareholders) invested.

Let's take a look of the Return On Equity trends of Relmada Therapeutics Inc:

  • The MRQ is -20.3%. Very bad. -2
  • The TTM is -28.6%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-20.3%TTM-28.6%+8.3%
TTM-28.6%YOY-21.3%-7.3%
TTM-28.6%5Y-83.3%+54.7%
5Y-83.3%10Y-46.6%-36.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.3%-11.9%-8.4%
TTM-28.6%-11.2%-17.4%
YOY-21.3%-10.6%-10.7%
5Y-83.3%-13.7%-69.6%
10Y-46.6%-14.5%-32.1%

1.2. Operating Efficiency of Relmada Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin
  • Measures how much profit a company makes for each $1 of sales after paying variable costs (production costs, wages) but before taxes.
  • Above 15% is considered healthy depending on the industry
  • An operating margin of 20% means the company generated $0,2 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Relmada Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-190.8%+190.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM--269.6%+269.6%
YOY--306.8%+306.8%
5Y--461.8%+461.8%
10Y-190.8%-546.8%+356.0%
1.2.2. Operating Ratio
  • Measures how efficient the company is creating its products or services while keeping operating costs low.
  • Below 1 is considered healthy depending on the industry
  • An operation ratio of 0.5 means that the operating costs are $0,5 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Relmada Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y2.364-2.364
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM-3.662-3.662
YOY-3.692-3.692
5Y-5.743-5.743
10Y2.3646.919-4.555

1.3. Liquidity of Relmada Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio
  • Measures if the company is able to pay off short-term debts (debts due within 1 year).
  • Above 1 is considered healthy depending on the industry.
  • A current ratio of 1.5 means the company has $1.5 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Relmada Therapeutics Inc:

  • The MRQ is 11.402. Very Good. +2
  • The TTM is 11.465. Very Good. +2
Trends
Current periodCompared to+/- 
MRQ11.402TTM11.465-0.063
TTM11.465YOY15.625-4.159
TTM11.4655Y15.574-4.109
5Y15.57410Y8.605+6.969
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.4025.318+6.084
TTM11.4656.219+5.246
YOY15.6256.366+9.259
5Y15.5746.760+8.814
10Y8.6056.520+2.085
1.3.2. Quick Ratio
  • Measures if the company is able to pay short-term debts (debts due within 1 year). But only uses the most liquid assets (cash, marketable securities and accounts retrievable).
  • Above 1 is considered healthy depending on the industry.
  • A quick ratio of 0,8 means the company can pay off $0,8 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Relmada Therapeutics Inc:

  • The MRQ is 20.437. Very good. +2
  • The TTM is 20.098. Very good. +2
Trends
Current periodCompared to+/- 
MRQ20.437TTM20.098+0.339
TTM20.098YOY30.013-9.916
TTM20.0985Y27.706-7.609
5Y27.70610Y14.584+13.122
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.4374.107+16.330
TTM20.0984.994+15.104
YOY30.0135.257+24.756
5Y27.7065.338+22.368
10Y14.5845.050+9.534

1.4. Solvency of Relmada Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt To Asset Ratio
  • Shows if the company is owned by creditors or shareholders.
  • Below 1 (100%) is considered healthy depending on the industry
  • A debt to asset ratio of 0.45 (45%) means that the company is financed with 45% credit and 55% is financed by it's owners (shareholders).

Let's take a look of the Debt To Asset Ratio trends of Relmada Therapeutics Inc:

  • The MRQ is 0.088. Very good. +2
  • The TTM is 0.106. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.088TTM0.106-0.018
TTM0.106YOY0.095+0.011
TTM0.1065Y0.766-0.660
5Y0.76610Y1.156-0.390
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0880.269-0.181
TTM0.1060.267-0.161
YOY0.0950.296-0.201
5Y0.7660.362+0.404
10Y1.1560.398+0.758
1.4.2. Debt to Equity Ratio
  • Measures the total debt versus the total shareholders equity (total assets - total liabilities).
  • Below 2 is considered healthy depending on the industry.
  • A debt to equity ratio of 0.84 means that company has $0,84 debt for each $1 in equity.

Let's take a look of the Debt to Equity Ratio trends of Relmada Therapeutics Inc:

  • The MRQ is 0.096. Very good. +2
  • The TTM is 0.123. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.096TTM0.123-0.027
TTM0.123YOY0.108+0.016
TTM0.1235Y0.924-0.801
5Y0.92410Y1.008-0.084
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0960.305-0.209
TTM0.1230.303-0.180
YOY0.1080.309-0.201
5Y0.9240.382+0.542
10Y1.0080.436+0.572

2. Market Valuation of Relmada Therapeutics Inc

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Relmada Therapeutics Inc:

  • The EOD is -4.469. Company is losing money. -2
  • The MRQ is -2.660. Company is losing money. -2
  • The TTM is -3.342. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-4.469MRQ-2.660-1.809
MRQ-2.660TTM-3.342+0.681
TTM-3.342YOY-8.978+5.637
TTM-3.3425Y-6.170+2.829
5Y-6.17010Y-7.323+1.153
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.469-2.088-2.381
MRQ-2.660-2.275-0.385
TTM-3.342-3.796+0.454
YOY-8.978-4.994-3.984
5Y-6.170-3.642-2.528
10Y-7.323-3.303-4.020
2.2. Price/Earnings-to-Growth Ratio

Let's take a look of the Price/Earnings-to-Growth Ratio trends of Relmada Therapeutics Inc:

  • The MRQ is -0.074. Very Bad. -2
  • The TTM is -0.048. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.074TTM-0.048-0.026
TTM-0.048YOY-0.179+0.131
TTM-0.0485Y0.026-0.074
5Y0.02610Y0.144-0.118
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0740.005-0.079
TTM-0.0480.020-0.068
YOY-0.1790.041-0.220
5Y0.0260.021+0.005
10Y0.1440.017+0.127

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Relmada Therapeutics Inc:

  • The EOD is 4.851. Neutral. Compare to industry.
  • The MRQ is 2.888. Good. +1
  • The TTM is 3.681. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD4.851MRQ2.888+1.963
MRQ2.888TTM3.681-0.793
TTM3.681YOY5.463-1.782
TTM3.6815Y5.329-1.648
5Y5.32910Y2.970+2.359
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.8511.808+3.043
MRQ2.8881.944+0.944
TTM3.6812.750+0.931
YOY5.4633.492+1.971
5Y5.3292.731+2.598
10Y2.9702.401+0.569

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Relmada Therapeutics Inc.

3.1. Institutions holding Relmada Therapeutics Inc

Institutions are holding 83.425% of the shares of Relmada Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31RTW INVESTMENTS, LLC8.461.4189254007435375016.1801
2022-03-31VR Adviser, LLC7.56079.9262227007200
2022-03-31RA Capital Management, LLC6.66121.1778200000000
2022-03-31Bvf Inc5.48681.7786164740000
2022-03-31Vanguard Group Inc4.40980.00091324014991138.0915
2022-03-31Point72 Asset Management, L.P.4.37110.1406131240036608738.6856
2022-06-30COWEN AND COMPANY, LLC3.55331.95651066854-97507-8.3743
2022-03-31Citadel Advisors Llc3.1290.0052939472645518219.5983
2022-03-31Great Point Partners LLC2.63125.1537900007268010.1322
2022-06-30Vivo Capital, LLC2.3511.34670588200
2022-06-30Parsons Capital Management Inc1.67790.865037767000.1391
2022-06-30Baker Bros Advisors LP1.6490.053349511300
2022-03-31Geode Capital Management, LLC1.51510.001545490411094732.2561
2022-03-31State Street Corporation1.4840.000644556412216337.7745
2022-06-30TANG CAPITAL MANAGEMENT LLC1.33221.15264000004000000
2022-03-31Longwood Capital Partners LLC1.13914.313342000-62000-15.3465
2022-03-31Sphera Funds Management Ltd.0.971.111291252-186956-39.0951
2022-03-31Millennium Management LLC0.93120.004279589-274403-49.5319
2022-03-31Morgan Stanley - Brokerage Accounts0.88620.001266065-307256-53.5923
2022-03-31Mangrove Partners0.85960.375525809412500093.9186
Total 61.058430.776218332525  

3.2. Funds holding Relmada Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-31Vanguard Total Stock Mkt Idx Inv2.94920.001988549800
2022-07-29iShares Russell 2000 ETF1.99440.0286598812159712.7402
2022-07-31Vanguard Extended Market Index Investor1.23460.0109370670190535.4187
2022-07-31Xtrackers LPX Private Equity Swap ETF 1C0.74891.855522484600
2022-07-29iShares Biotechnology ETF0.6970.0669209281-324-0.1546
2022-05-31Fidelity® Small Cap Index0.64530.019419376300
2022-07-29iShares Russell 2000 Growth ETF0.52240.0409156863-183-0.1165
2022-06-30Fidelity® Extended Market Index0.49470.00961485401753713.3867
2022-06-30Candriam Eqs L Biotech C USD Cap0.47360.168114218600
2022-07-31State St Russell Sm/Mid Cp® Indx NL Cl C0.42930.00991289001300011.2166
2022-07-31SPDR® S&P Pharmaceuticals ETF0.41911.4468125826-1213-0.9548
2022-07-31State St Russell Sm Cap® Indx NL Cl C0.32730.0276982811060012.0893
2022-06-30NT R2000 Index Fund - NL0.25910.02267779070649.9878
2022-07-29iShares Russell 2000 Value ETF0.24220.01517272000
2022-06-30DFA US Small Cap I0.22710.00996818143106.748
2022-07-31Vanguard Russell 2000 ETF0.22150.027766496-2413-3.5017
2022-06-30BlackRock Extended Mkt Composite0.21880.010565696656960
2022-07-31Schwab Small Cap Index0.20520.0283616236561.076
2022-06-30NT R2000 Growth Index Fund - NL0.19670.032759051-14685-19.9156
2022-06-30BlackRock Extended Equity Market K0.1950.0104585401443832.7377
Total 12.70143.84333813563  

3.3. Insider Transactions

Insiders are holding 1.292% of the shares of Relmada Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-06-30Sergio TraversaSELL1601219.1388774
2022-04-04Paul Edward KellySELL1000030.04187295
2021-09-22Charles J CasamentoSELL660029
2021-07-15Charles J CasamentoSELL330031.545854
2021-06-01Charles J CasamentoSELL300033.349430
2021-04-01Charles J CasamentoSELL300035.4314641
2021-03-10Maged ShenoudaSELL237335.1112228
2021-03-09Paul Edward KellySELL500035.71172295
2021-03-09Sergio TraversaSELL701735.6598774
2021-03-08Maged ShenoudaSELL1003512228
2021-02-10Maged ShenoudaSELL241035.213600
2021-02-10Sergio TraversaSELL193035.2899980
2021-02-08Maged ShenoudaSELL360335.0413600
2021-02-08Paul Edward KellySELL150035.04165864
2021-02-08Sergio TraversaSELL331335.0399980
2021-02-03Maged ShenoudaSELL320035.045428
2021-02-03Sergio TraversaSELL327835.0792052
2021-02-01Charles J. CasamentoSELL300033.63
2021-01-27Maged ShenoudaSELL300031.935228
2021-01-27Paul Edward KellySELL500032.46152295

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Relmada Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--6.5767.515-12%6.344+4%3.834+71%2.227+195%
Current Ratio--11.40211.465-1%15.625-27%15.574-27%8.605+32%
Debt To Asset Ratio--0.0880.106-17%0.095-8%0.766-89%1.156-92%
Debt To Equity Ratio--0.0960.123-22%0.108-11%0.924-90%1.008-90%
Eps---1.334-1.785+34%-1.311-2%-1.017-24%-0.864-35%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.005-1%
Net Profit Margin----0%-0%-0%-2.1890%
Operating Margin----0%-0%-0%-1.9080%
Operating Ratio----0%-0%-0%2.364-100%
Pb Ratio4.851+40%2.8883.681-22%5.463-47%5.329-46%2.970-3%
Pe Ratio-4.469-68%-2.660-3.342+26%-8.978+237%-6.170+132%-7.323+175%
Peg Ratio---0.074-0.048-35%-0.179+142%0.026-380%0.144-151%
Price Per Share31.900+40%18.99023.680-20%34.228-45%18.462+3%9.949+91%
Quick Ratio--20.43720.098+2%30.013-32%27.706-26%14.584+40%
Return On Assets---0.185-0.246+33%-0.191+3%-0.516+179%-0.644+248%
Return On Equity---0.203-0.286+41%-0.213+5%-0.833+311%-0.466+130%
 EOD+1 -2MRQTTM+9 -3YOY+7 -55Y+7 -510Y+10 -4

4.2. Fundamental Score

Let's check the fundamental score of Relmada Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.469
Price to Book Ratio (EOD)Between0-14.851
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than120.437
Current Ratio (MRQ)Greater than111.402
Debt To Asset Ratio (MRQ)Less than10.088
Debt to Equity Ratio (MRQ)Less than10.096
Return On Equity (MRQ)Greater than0.15-0.203
Return on Assets (MRQ)Greater than0.05-0.185
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Relmada Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.792
Ma 20Greater thanMa 5031.266
Ma 50Greater thanMa 10028.488
Ma 100Greater thanMa 20023.978
OpenGreater thanClose29.960
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets215,772
Total Liabilities18,921
Total Stockholder Equity196,851
 As reported
Total Liabilities 18,921
Total Stockholder Equity+ 196,851
Total Assets = 215,772

Assets

Total Assets215,772
Total Current Assets215,737
Long-term Assets215,737
Total Current Assets
Cash And Cash Equivalents 37,261
Short-term Investments 174,694
Net Receivables 42
Other Current Assets 3,740
Total Current Assets  (as reported)215,737
Total Current Assets  (calculated)215,737
+/-0
Long-term Assets
Other Assets 35
Long-term Assets  (as reported)35
Long-term Assets  (calculated)35
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities18,921
Long-term Liabilities0
Total Stockholder Equity196,851
Total Current Liabilities
Accounts payable 7,540
Other Current Liabilities 11,381
Total Current Liabilities  (as reported)18,921
Total Current Liabilities  (calculated)18,921
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock30
Retained Earnings -384,748
Other Stockholders Equity 581,569
Total Stockholder Equity (as reported)196,851
Total Stockholder Equity (calculated)196,851
+/-0
Other
Capital Stock30
Cash and Short Term Investments 211,955
Common Stock Shares Outstanding 29,936
Liabilities and Stockholders Equity 215,772
Net Debt -37,261
Net Invested Capital 196,851
Net Tangible Assets 196,851
Net Working Capital 196,816



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-31
> Total Assets 
0
0
18
0
10
5
5
12
12
10
25,760
27,847
32,792
27,850
24,393
20,485
16,604
12,718
10,244
7,922
6,225
4,170
2,837
5,614
6,574
4,796
3,048
1,556
3,299
2,604
10,220
8,514
117,136
115,421
134,559
125,599
118,186
103,867
110,769
90,934
223,326
225,808
215,772
215,772225,808223,32690,934110,769103,867118,186125,599134,559115,421117,1368,51410,2202,6043,2991,5563,0484,7966,5745,6142,8374,1706,2257,92210,24412,71816,60420,48524,39327,85032,79227,84725,760101212551001800
   > Total Current Assets 
0
0
18
0
10
3
3
11
11
9
25,740
27,818
32,756
27,814
23,968
20,050
15,656
11,775
9,298
6,972
5,296
3,244
2,475
5,265
6,242
4,481
2,738
1,270
3,032
2,330
9,984
8,298
116,940
115,245
134,405
125,465
118,074
103,776
110,700
90,887
223,298
225,779
215,737
215,737225,779223,29890,887110,700103,776118,074125,465134,405115,245116,9408,2989,9842,3303,0321,2702,7384,4816,2425,2652,4753,2445,2966,9729,29811,77515,65620,05023,96827,81432,75627,81825,74091111331001800
       Cash And Cash Equivalents 
0
0
9
0
8
1
1
6
6
3
25,560
27,391
31,419
26,956
22,470
19,165
15,128
11,349
8,500
6,222
4,714
2,757
1,711
4,685
5,940
4,258
2,239
887
2,427
2,054
9,217
7,850
36,279
12,226
13,824
7,545
2,495
3,804
4,669
11,449
44,443
44,934
37,261
37,26144,93444,44311,4494,6693,8042,4957,54513,82412,22636,2797,8509,2172,0542,4278872,2394,2585,9404,6851,7112,7574,7146,2228,50011,34915,12819,16522,47026,95631,41927,39125,5603661180900
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
80,165
102,691
120,264
115,594
114,596
98,900
104,399
76,638
167,466
175,716
174,694
174,694175,716167,46676,638104,39998,900114,596115,594120,264102,69180,16500000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
232
234
2
0
343
211
62
63
72
66
67
69
247
72
73
82
76
78
152
81
83
85
86
65
42
426586858381152787682737224769676672636221134302234232000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
428
1,337
858
1,498
885
528
427
798
748
579
487
472
369
240
160
427
317
538
0
0
0
0
246
241
2,249
830
991
1,549
2,715
11,302
5,064
3,740
3,7405,06411,3022,7151,5499918302,24924124600005383174271602403694724875797487984275288851,4988581,33742800000000000
   > Long-term Assets 
0
0
0
0
0
2
2
1
1
1
20
29
36
35
425
434
949
942
946
951
930
927
362
348
332
315
310
286
267
273
235
216
196
176
155
134
113
91
69
47
28
28
35
352828476991113134155176196216235273267286310315332348362927930951946942949434425353629201112200000
       Property Plant Equipment 
0
0
0
0
0
2
2
1
1
1
10
17
24
23
24
22
536
530
531
536
515
512
2
4
4
3
12
11
9
8
7
6
5
4
3
2
1
0
0
0
0
0
0
000000123456789111234425125155365315305362224232417101112200000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
338
322
306
290
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000002903063223380000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
12
12
12
401
412
413
413
415
415
415
414
360
345
328
311
298
275
258
44
228
210
25
172
152
132
111
90
69
47
28
28
35
352828476990111132152172252102284425827529831132834536041441541541541341341240112121200000000000
> Total Liabilities 
0
0
7
0
12
26
26
40
40
41
26,870
48,570
28,199
25,356
15,583
6,649
4,840
2,513
3,202
2,348
1,550
1,368
1,377
4,149
5,853
7,112
8,561
10,296
1,864
2,130
2,606
2,537
1,458
2,261
2,326
3,389
12,603
12,719
13,917
18,247
15,061
15,409
18,921
18,92115,40915,06118,24713,91712,71912,6033,3892,3262,2611,4582,5372,6062,1301,86410,2968,5617,1125,8534,1491,3771,3681,5502,3483,2022,5134,8406,64915,58325,35628,19948,57026,8704140402626120700
   > Total Current Liabilities 
0
0
7
0
12
26
26
40
40
41
26,770
48,470
28,099
25,256
15,583
6,649
4,785
2,404
3,061
2,214
1,413
1,229
1,377
3,470
4,575
5,535
5,905
7,103
1,864
2,130
2,606
2,537
1,458
2,261
2,326
3,389
12,603
12,719
13,917
18,247
15,061
15,409
18,921
18,92115,40915,06118,24713,91712,71912,6033,3892,3262,2611,4582,5372,6062,1301,8647,1035,9055,5354,5753,4701,3771,2291,4132,2143,0612,4044,7856,64915,58325,25628,09948,47026,7704140402626120700
       Short-term Debt 
0
0
0
0
0
0
0
0
0
840
60
148
38
24,467
264
176
89
614
274
164
110
28
277
194
111
28
285
200
115
29
364
256
110
110
0
0
0
0
0
0
0
0
0
0000000001101102563642911520028528111194277281101642746148917626424,4673814860840000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
634
307
277
873
1,389
1,604
2,942
0
0
29
364
256
110
0
0
0
0
0
0
0
0
0
0
000000000011025636429002,9421,6041,38987327730763400000000000000000000
       Accounts payable 
0
0
0
0
12
26
34
40
41
0
0
1,504
1,492
789
1,318
1,765
3,250
1,790
1,895
1,077
780
922
924
758
780
1,550
1,425
1,986
1,749
1,080
924
1,267
523
1,103
965
729
8,346
8,083
10,456
12,709
11,193
10,670
7,540
7,54010,67011,19312,70910,4568,0838,3467299651,1035231,2679241,0801,7491,9861,4251,5507807589249227801,0771,8951,7903,2501,7651,3187891,4921,5040041403426120000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
47,697
27,091
24,866
14,484
5,323
3,009
1,660
1,527
1,378
996
866
570
2,925
4,178
3,957
4,195
405
1,106
0
0
500
0
0
0
2,661
4,257
4,637
3,461
5,539
3,868
4,739
11,381
11,3814,7393,8685,5393,4614,6374,2572,661000500001,1064054,1953,9574,1782,9255708669961,3781,5271,6603,0095,32314,48424,86627,09147,69700000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
100
100
100
100
100
0
0
55
109
141
135
137
139
0
679
1,278
1,576
2,656
3,193
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000003,1932,6561,5761,27867901391371351411095500100100100100100000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
679
1,278
1,576
2,656
3,193
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000003,1932,6561,5761,27867900000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
100
100
100
0
0
55
109
141
134
137
139
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000139137134141109550010010010000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000550000000000000000
> Total Stockholder Equity
0
0
0
0
-2
-21
-14
-28
-31
0
0
-20,722
4,593
2,494
8,810
13,836
11,764
10,205
7,042
5,574
4,675
2,802
1,460
1,465
721
-2,316
-5,513
-8,740
1,435
474
7,613
5,977
115,678
113,160
132,233
122,210
105,583
91,147
96,853
72,687
208,265
210,398
196,851
196,851210,398208,26572,68796,85391,147105,583122,210132,233113,160115,6785,9777,6134741,435-8,740-5,513-2,3167211,4651,4602,8024,6755,5747,04210,20511,76413,8368,8102,4944,593-20,72200-31-28-14-21-20000
   Common Stock
0
0
0
0
24
24
29
29
29
0
0
44
54
54
11
11
12
12
12
12
12
12
13
13
13
13
13
13
30
31
10
10
14
15
16
16
16
17
17
18
28
29
30
30292818171716161615141010313013131313131312121212121211115454440029292924240000
   Retained Earnings Total Equity00000-201,5300-158,553-141,651-130,5320-115,332-111,662-107,540-104,854-97,724-94,344-90,994-87,792-86,365-85,383-83,750-81,768-80,738-79,097-75,780-73,920-71,459-76,122-82,165-79,702-85,15700-75-72-57-45-250000
   Accumulated Other Comprehensive Income 0000000-15-14-13-12-11-10-8-7-6-5-4-3-3-2-130-107-83-64-44-16000000-1-100000000
   Capital Surplus 
0
0
0
0
0
0
15
15
15
0
0
64,388
84,240
84,604
84,921
85,284
85,672
85,972
86,127
86,299
86,431
86,540
86,831
87,817
88,501
88,666
88,819
88,971
106,259
107,983
119,237
121,299
235,523
243,677
273,868
280,747
0
292,661
0
0
0
0
0
00000292,6610280,747273,868243,677235,523121,299119,237107,983106,25988,97188,81988,66688,50187,81786,83186,54086,43186,29986,12785,97285,67285,28484,92184,60484,24064,38800151515000000
   Treasury Stock0000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
280,762
284,882
292,661
324,918
0
513,304
555,182
581,569
581,569555,182513,3040324,918292,661284,882280,76200000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2022-06-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-125,703
Operating Income-125,703-125,703
 
Operating Expense (+$)
Research Development90,622
Selling General Administrative35,082
Selling And Marketing Expenses-
Operating Expense125,703125,703
 
Net Interest Income (+$)
Interest Income1,199
Interest Expense-1,199
Net Interest Income1,1990
 
Pretax Income (+$)
Operating Income-125,703
Net Interest Income1,199
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-125,752-125,655
EBIT - interestExpense = -125,655
-125,752
-124,553
Interest Expense1,199
Earnings Before Interest and Taxes (ebit)-124,456-124,553
Earnings Before Interest and Taxes (ebitda)-124,455
 
After tax Income (+$)
Income Before Tax-125,752
Tax Provision--
Net Income From Continuing Ops-125,752-125,752
Net Income-125,752
Net Income Applicable To Common Shares-125,752
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses125,703
Total Other Income/Expenses Net-48-1,199
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
DAAPL.CC
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DAAPL.CC.

DAAPL.CC Daily Candlestick Chart
UIP.CC
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of UIP.CC.

UIP.CC Daily Candlestick Chart
TRC.CC
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRC.CC.

TRC.CC Daily Candlestick Chart
TIX.CC
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TIX.CC.

TIX.CC Daily Candlestick Chart
THC.CC
1 hour ago

I found you a MACD Bearish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TERC.CC
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
TBTC.CC
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TBTC.CC.

TBTC.CC Daily Candlestick Chart
SWACE.CC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SWACE.CC.

SWACE.CC Daily Candlestick Chart
START.CC
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of START.CC.

START.CC Daily Candlestick Chart
SNC.CC
1 hour ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SAVG.CC
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SAVG.CC.

SAVG.CC Daily Candlestick Chart
RPZX.CC
1 hour ago

I found you a Golden Cross on the daily chart of RPZX.CC.

RPZX.CC Daily Candlestick Chart
RIO.CC
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RIO.CC.

RIO.CC Daily Candlestick Chart
PYRK.CC
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRK.CC.

PYRK.CC Daily Candlestick Chart
PLAY.CC
1 hour ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
pBTC35A.CC
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of pBTC35A.CC.

pBTC35A.CC Daily Candlestick Chart
PBTC.CC
2 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PBTC.CC.

PBTC.CC Daily Candlestick Chart
PASC.CC
2 hours ago

I found you a Golden Cross on the daily chart of PASC.CC.

PASC.CC Daily Candlestick Chart
OPCT.CC
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of OPCT.CC.

OPCT.CC Daily Candlestick Chart
NCDT.CC
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NCDT.CC.

NCDT.CC Daily Candlestick Chart
MSWAP.CC
2 hours ago

I found you a Death Cross on the daily chart of MSWAP.CC.

MSWAP.CC Daily Candlestick Chart
MERI.CC
2 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of MERI.CC.

MERI.CC Daily Candlestick Chart
MBC.CC
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MBC.CC.

MBC.CC Daily Candlestick Chart